Elevance Health ROE 2010-2024 | ELV
Current and historical return on equity (ROE) values for Elevance Health (ELV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elevance Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $6.42B | $43.88B | 15.44% |
| 2024-06-30 | $6.69B | $42.30B | 16.63% |
| 2024-03-31 | $6.24B | $40.71B | 15.91% |
| 2023-12-31 | $5.99B | $39.41B | 15.58% |
| 2023-09-30 | $6.00B | $38.54B | 15.92% |
| 2023-06-30 | $6.31B | $38.31B | 17.04% |
| 2023-03-31 | $6.09B | $37.46B | 16.73% |
| 2022-12-31 | $5.89B | $36.33B | 16.34% |
| 2022-09-30 | $6.22B | $36.04B | 17.27% |
| 2022-06-30 | $6.13B | $35.87B | 17.04% |
| 2022-03-31 | $6.28B | $36.03B | 17.57% |
| 2021-12-31 | $6.16B | $36.13B | 17.48% |
| 2021-09-30 | $5.52B | $35.81B | 16.00% |
| 2021-06-30 | $4.23B | $35.05B | 12.44% |
| 2021-03-31 | $4.71B | $33.92B | 13.92% |
| 2020-12-31 | $4.57B | $33.20B | 13.72% |
| 2020-09-30 | $4.96B | $33.92B | 15.04% |
| 2020-06-30 | $5.92B | $34.46B | 18.31% |
| 2020-03-31 | $4.78B | $31.69B | 15.23% |
| 2019-12-31 | $4.81B | $31.73B | 15.53% |
| 2019-09-30 | $4.30B | $31.33B | 14.24% |
| 2019-06-30 | $4.07B | $30.79B | 13.76% |
| 2019-03-31 | $3.99B | $30.00B | 13.71% |
| 2018-12-31 | $3.75B | $28.54B | 13.23% |
| 2018-09-30 | $4.56B | $29.09B | 16.37% |
| 2018-06-30 | $4.34B | $28.73B | 16.06% |
| 2018-03-31 | $4.15B | $27.01B | 15.66% |
| 2017-12-31 | $3.84B | $26.50B | 14.64% |
| 2017-09-30 | $2.98B | $25.95B | 11.51% |
| 2017-06-30 | $2.85B | $26.43B | 11.14% |
| 2017-03-31 | $2.78B | $26.09B | 11.09% |
| 2016-12-31 | $2.47B | $25.10B | 10.12% |
| 2016-09-30 | $2.28B | $24.74B | 9.56% |
| 2016-06-30 | $2.32B | $24.23B | 9.87% |
| 2016-03-31 | $2.40B | $23.55B | 10.33% |
| 2015-12-31 | $2.56B | $23.04B | 10.93% |
| 2015-09-30 | $2.89B | $23.24B | 12.17% |
| 2015-06-30 | $2.86B | $23.06B | 11.93% |
| 2015-03-31 | $2.73B | $24.33B | 11.24% |
| 2014-12-31 | $2.57B | $24.25B | 10.57% |
| 2014-09-30 | $2.21B | $24.29B | 9.04% |
| 2014-06-30 | $2.24B | $24.38B | 9.10% |
| 2014-03-31 | $2.31B | $24.35B | 9.37% |
| 2013-12-31 | $2.49B | $24.77B | 10.12% |
| 2013-09-30 | $2.81B | $24.81B | 11.51% |
| 2013-06-30 | $2.84B | $24.53B | 11.78% |
| 2013-03-31 | $2.68B | $24.32B | 11.23% |
| 2012-12-31 | $2.66B | $23.80B | 11.21% |
| 2012-09-30 | $2.53B | $23.82B | 10.72% |
| 2012-06-30 | $2.52B | $23.64B | 10.70% |
| 2012-03-31 | $2.58B | $23.53B | 10.88% |
| 2011-12-31 | $2.65B | $23.29B | 11.13% |
| 2011-09-30 | $2.86B | $23.72B | 11.96% |
| 2011-06-30 | $2.92B | $24.18B | 12.11% |
| 2011-03-31 | $2.94B | $23.98B | 12.24% |
| 2010-12-31 | $2.89B | $23.81B | 11.97% |
| 2010-09-30 | $5.08B | $24.36B | 20.83% |
| 2010-06-30 | $5.07B | $23.79B | 21.12% |
| 2010-03-31 | $5.04B | $24.52B | 21.35% |
| 2009-12-31 | $4.75B | $24.86B | 20.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $89.358B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $46.783B | 17.59 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $20.907B | 0.00 |
| ICON (ICLR) | Ireland | $16.343B | 14.56 |
| Avantor (AVTR) | United States | $15.048B | 22.56 |
| Revvity (RVTY) | United States | $14.408B | 25.03 |
| BioMerieux (BMXMF) | France | $13.788B | 0.00 |
| Viatris (VTRS) | United States | $13.488B | 4.15 |
| Solventum (SOLV) | United States | $12.699B | 0.00 |
| CochLear (CHEOY) | Australia | $12.341B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.485B | 29.54 |
| Doximity (DOCS) | United States | $10.029B | 59.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.551B | 0.00 |
| HealthEquity (HQY) | United States | $8.876B | 44.53 |
| Charles River Laboratories (CRL) | United States | $8.361B | 16.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.244B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.118B | 28.46 |
| Organon (OGN) | United States | $4.054B | 4.09 |
| Sotera Health (SHC) | United States | $3.676B | 19.67 |
| BrightSpring Health Services (BTSG) | United States | $3.230B | 68.70 |
| Alignment Healthcare (ALHC) | United States | $2.795B | 0.00 |
| Concentras Parent (CON) | United States | $2.691B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.566B | 29.26 |
| Premier (PINC) | United States | $2.156B | 11.22 |
| PACS (PACS) | United States | $2.106B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.013B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.909B | 0.00 |
| Progyny (PGNY) | United States | $1.788B | 36.21 |
| GoodRx Holdings (GDRX) | United States | $1.742B | 45.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Agilon Health (AGL) | United States | $1.273B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.189B | 11.63 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| Embecta (EMBC) | United States | $1.086B | 7.59 |
| AMN Healthcare Services Inc (AMN) | United States | $0.986B | 6.67 |
| Establishment Labs Holdings (ESTA) | $0.968B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.624B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.429B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| DocGo (DCGO) | United States | $0.426B | 16.04 |
| Enhabit (EHAB) | United States | $0.402B | 34.74 |
| MultiPlan (MPLN) | United States | $0.260B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.239B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Beauty Health (SKIN) | United States | $0.216B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Nutex Health (NUTX) | United States | $0.206B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.167B | 0.00 |
| So-Young (SY) | China | $0.110B | 18.60 |
| ModivCare (MODV) | United States | $0.093B | 5.03 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.63 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |